New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
06:31 EDTEWEdwards Lifesciences downgraded to Sell from Neutral at UBS
UBS downgraded Edwards Lifesciences due to the slower than expected U.S. Sapien launch and European deceleration. Price target lowered to $80 from $95.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
08:34 EDTEWEdwards Lifesciences should be bought on strong TAVR data, says Wells Fargo
Wells Fargo commends buying shares of Edwards Lifesciences after the firm viewed the most recent Transcatheter Valve Therapies registry update and estimated that the TAVR market may have grown 20% sequentially last quarter, versus its previous estimate of 1% sequential growth. The firm keeps an Outperform rating on Edwards.
07:17 EDTEWSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use